4:00 PM - 5:00 PM
The Outlook for Vaccines and Therapeutics
The Stanford Medicine Alummi Association is proud to offer our all new virtual Alumni to Alumni Speaker Series! This series features accomplished School of Medicine alumni sharing their knowledge and experience in a variety of heathcare, research, start-up and private sector settings, highlighting the diversity, innovation, dedication and impact of the Stanford Medicine community.
Dr. Bonnie Maldonado has been on the forefront of Covid19 efforts at Stanford Medicine as well as contributing her expertise to government policy both on the state and national levels. She has been closely involved in Stanford’s research on tracking, testing, treating, and curing COVID 19 patients and identifying strategies to address global health in a pandemic. Join us to hear about the latest developments for coronavirus vaccines and therapeutics, and the outlook for the future of our global health.
Yvonne (Bonnie) Maldonado, MD '81
Senior Associate Dean for Faculty Development and Diversity
Taube Professor of Global Health and Infectious Diseases and Professor of Pediatrics (Infectious Diseases) and of Epidemiology and Population Health
Dr. Yvonne "Bonnie" Maldonado is a Professor of Pediatrics and of Health Research and Policy at Stanford University, with a focus on Infectious Diseases. She founded Stanford's pediatric HIV Clinic and serves as Chief of the Division of Pediatric Infectious Disease. In addition, she is an advocate for diversity, equity, and inclusion, serving as Stanford's Associate Dean of Faculty Development and Diversity.
Dr. Maldonado has contributed her medical expertise to governmental policy, serving on the National Vaccine Advisory Committee through the United States Department of Health and Human Services and as a member of Governor Newsom’s California Initiative to Advance Precision Medicine Advisory Council. She is the Chair of the committee on infectious diseases at the American Academy of Pediatrics and serves as a Senior Fellow at the Stanford Center for Innovation in Global Health.
Her research focuses on the epidemiology and prevention of infectious diseases, such as rotavirus, measles, mumps, rubella, polio, and pediatric HIV infection. Maldonado's research program also focuses on the development and implementation of vaccines. Most recently, Maldonado and her team have been involved in many of the studies at Stanford University seeking to understand the biology and epidemiology of SARS-CoV-2 (Covid19). She has worked on a study of the accuracy of three different self-administered nasal swab techniques, which would allow individuals to test themselves for infection without the need to come to the hospital. In the meantime, she has spoken of the importance of drive-through COVID-19 testing, which Stanford implemented to minimize the risk of spreading the disease at hospitals. She also launched a study to understand how coronavirus is transmitted within a household. Her team also worked to develop and implement an antibody test to determine if someone had contracted coronavirus; the test was approved by the Food and Drug Administration in early April 2020.
Raised in Los Angeles, Maldonado is the daughter of Mexican immigrants and was the first in her family to attend college. She received her Bachelor’s Degree from University of California, Los Angeles and then attended Stanford University School of Medicine, where she received her MD degree in 1981. She then performed her residency in pediatrics at Johns Hopkins Hospital, where she remained for her fellowship in pediatric infectious diseases. In 2018, the Stanford Medicine Alumni Association presented her with the RISE Award for outstanding lifetime contributions to the Stanford Medicine community.David Magnus received his PhD in philosophy from Stanford University, and currently co-chairs Stanford Hospital and Clinic’s Ethics Committee which provides consultation to doctors, patients and families on issues concerning surrogate decision making at the end-of-life and organ donation. He is a member of Stanford’s End of Life Work Group, Palliative Care Board and the newly formed Innovative Care Committee.